Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations Despite Biological Therapy.

IF 4 3区医学 Q1 DERMATOLOGY

Dermatitis Pub Date : 2024-01-01 Epub Date: 2023-03-28 DOI:10.1089/derm.2023.0011

Filomena Russo, Vittoria Cioppa, Alessandra Cartocci, Nicola Milanesi, Angelo Massimiliano D'Erme, Laura Lazzeri, Pietro Rubegni, Francesco Santi

引用次数: 0

查看原文本刊更多论文

杜匹单抗与特应性皮炎复发：一项观察性研究，旨在确定在接受生物疗法后仍病情加重的患者的共同临床特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatitis 医学-皮肤病学

CiteScore

5.30

自引率

11.50%

发文量

251

审稿时长

>12 weeks

期刊介绍： Dermatitis is owned by the American Contact Dermatitis Society and is the home journal of 4 other organizations, namely Societa Italiana di Dermatologica Allergologica Professionale e Ambientale, Experimental Contact Dermatitis Research Group, International Contact Dermatitis Research Group, and North American Contact Dermatitis Group. Dermatitis focuses on contact, atopic, occupational, and drug dermatitis, and welcomes manuscript submissions in these fields, with emphasis on reviews, studies, reports, and letters. Annual sections include Contact Allergen of the Year and Contact Allergen Alternatives, for which papers are chosen or invited by the respective section editor. Other sections unique to the journal are Pearls & Zebras, Product Allergen Watch, and news, features, or meeting abstracts from participating organizations.